Literature DB >> 11205719

Prothrombotic disorders and ischemic stroke in children.

A K Chan1, G deVeber.   

Abstract

Childhood ischemic stroke, including arterial ischemic stroke (AIS) and sinovenous thrombosis (SVT), is relatively rare in children but can result in devastating morbidity and mortality. An understanding of the etiology of childhood stroke is important because strategies for primary and secondary prevention can be devised. Prothrombotic disorders may contribute to the etiology of childhood stroke, and include deficiencies of antithrombin, protein C, protein S, plasminogen, and presence of Factor V Leiden, Prothrombin gene G20210A, dysfibrinogenemia, antiphospholipid antibodies, hyperhomocysteinemia, and elevated lipoprotein (a). The overall incidence of prothrombotic disorders in childhood AIS is estimated to be 20% to 50% in most studies and, in childhood SVT, to be 33% to 99%. In addition, hyperlipidemia, polycythemia, iron deficiency anemia, and platelet disorders may result in a prothrombotic state associated with ischemic stroke. The etiologic contribution of these prothrombotic disorders to initial and recurrent stroke has not been clearly defined; however, additional risk factors are usually present in affected children. Given the prevalence of prothrombotic disorders in childhood stroke, and their likely causative role, children with stroke should be screened for prothrombotic disorders. Future prospective and multicenter studies will elucidate the contribution of specific prothrombotic disorders to initial and recurrent stroke, and optimal therapy.

Entities:  

Mesh:

Year:  2000        PMID: 11205719     DOI: 10.1053/spen.2000.20075

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  10 in total

Review 1.  Imaging in childhood arterial ischaemic stroke.

Authors:  Brynmor P Jones; Vijya Ganesan; Dawn E Saunders; W Kling Chong
Journal:  Neuroradiology       Date:  2010-05-06       Impact factor: 2.804

Review 2.  Cerebral sinovenous thrombosis in children.

Authors:  Jessica Carpenter; Tammy Tsuchida
Journal:  Curr Neurol Neurosci Rep       Date:  2007-03       Impact factor: 5.081

3.  Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.

Authors:  Nicolas Dognin; Erwan Salaun; Catherine Champagne; Guillaume Domain; Gilles O'Hara; François Philippon; Jean-Michel Paradis; Laurent Faroux; Jonathan Beaudoin; Kim O'Connor; Mathieu Bernier; Josep Rodés-Cabau; Jean Champagne
Journal:  J Interv Card Electrophysiol       Date:  2021-11-25       Impact factor: 1.759

Review 4.  The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.

Authors:  Ilona Kopyta; Beata Sarecka-Hujar; Joanna Sordyl; Ryszard Sordyl
Journal:  Mol Biol Rep       Date:  2014-03-01       Impact factor: 2.316

5.  Pediatric and newborn stroke.

Authors:  Sharon Goodman; Steven Pavlakis
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

Review 6.  [Pediatric stroke].

Authors:  M Hörmann
Journal:  Radiologe       Date:  2008-05       Impact factor: 0.635

Review 7.  Inherited and acquired risk factors for arterial ischemic stroke in childhood.

Authors:  Giuseppe Lippi; Massimo Franchini; Martina Montagnana; Gian Luca Salvagno; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-02-10       Impact factor: 2.300

Review 8.  The paediatric overview.

Authors:  Stuart H Green
Journal:  Pediatr Radiol       Date:  2003-11-28

9.  Multiple cerebral sinus thromboses complicating meningococcal meningitis: a pediatric case report.

Authors:  Elena Bozzola; Mauro Bozzola; Giovanna Stefania Colafati; Valeria Calcaterra; Annachiara Vittucci; Matteo Luciani; Alberto Villani
Journal:  BMC Pediatr       Date:  2014-06-13       Impact factor: 2.125

10.  Risk factors, types and outcomes of arterial ischemic stroke in Polish pediatric patients: a retrospective single-center study.

Authors:  Beata Sarecka-Hujar; Ilona Kopyta; Dorota Raczkiewicz
Journal:  Arch Med Sci       Date:  2018-04-09       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.